{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:29:01Z","timestamp":1794047341586,"version":"4.8.0"},"reference-count":11,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"9","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2019.240762","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T12:15:37Z","timestamp":1578572137000},"page":"e474-479","source":"Crossref","is-referenced-by-count":13,"title":["Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care"],"prefix":"10.3324","volume":"105","author":[{"given":"Faouzi","family":"Djebbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Panitsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby A.","family":"Eyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Prodger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fearn","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil","family":"Khera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Vallance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaimal","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Peniket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"2565","doi-asserted-by":"crossref","unstructured":"Augustson BM, Begum G, Dunn JA. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002\u2014Medical Research Council Adult Leukaemia Working Party. J Clin Oncology. 2005; 23(36):9219-9226. Google Scholar","DOI":"10.1200\/JCO.2005.03.2086"},{"key":"2566","doi-asserted-by":"crossref","unstructured":"Teh BW, Harrison SJ, Pellegrini M, Thursky KA, Worth LJ, Slavin M.A.. Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection. Blood Rev. 2014; 28(2):75-86. Google Scholar","DOI":"10.1016\/j.blre.2014.01.004"},{"key":"2567","doi-asserted-by":"crossref","unstructured":"Mateos MV, San Miguel JF. Management of multiple myeloma in the newly diagnosed patient. Hematology Am Soc Hematol Educ Program. 2017; 1:498-507. Google Scholar","DOI":"10.1182\/asheducation-2017.1.498"},{"key":"2568","doi-asserted-by":"crossref","unstructured":"Zweegman S, Palumbo A, Bringhen S, Sonneveld P.. Age and aging in blood disorders: multiple myeloma. Haematologica. 2014; 99(7):1133-1137. Google Scholar","DOI":"10.3324\/haematol.2014.110296"},{"key":"2569","doi-asserted-by":"crossref","unstructured":"Offidani M, Corvatta L, Bringhen L. Infection complications in 476 patients with newly diagnosed multiple myeloma treated with lenalidomide or bortezomib combinations. Blood. 2015; 126(23):5365. Google Scholar","DOI":"10.1182\/blood.V126.23.5365.5365"},{"key":"2570","doi-asserted-by":"crossref","unstructured":"Simonsson B, Brenning G, K\u00e4llander C, Ahre A.. Prognostic value of serum lactic dehydrogenase (S-LDH) in multiple myeloma. Eur J Clin Invest. 1987; 17(4):336-339. Google Scholar","DOI":"10.1111\/j.1365-2362.1987.tb02197.x"},{"key":"2571","doi-asserted-by":"crossref","unstructured":"Dumontet C, Hulin C, Dimopoulos MA. A predictive model for risk of early grade \u2265 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial. Leukemia. 2018; 32(6):1404-1413. Google Scholar","DOI":"10.1038\/s41375-018-0133-x"},{"key":"2572","doi-asserted-by":"crossref","unstructured":"Teh BW, Harrison SJ, Worth LJ, Spelman T, Thursky KA, Slavin MA. Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy. Br J Haematol. 2015; 171(1):100-108. Google Scholar","DOI":"10.1111\/bjh.13532"},{"key":"2573","doi-asserted-by":"crossref","unstructured":"Benboubker L, Dimopoulos MA, Dispenzieri A. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. N Engl J Med. 2014; 371(10):906-917. Google Scholar","DOI":"10.1056\/NEJMoa1402551"},{"key":"2574","doi-asserted-by":"crossref","unstructured":"Mateos MV, Dimopoulos MA, Cavo M. Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma. N Engl J Med. 2018; 378(6):518-528. Google Scholar","DOI":"10.1056\/NEJMoa1714678"},{"key":"2575","doi-asserted-by":"crossref","unstructured":"Drayson MT, Bowcock S, Planche T. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. Lancet Oncol. 2019; 20(12):1760-1772. Google Scholar","DOI":"10.1016\/S1470-2045(19)30506-6"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/9867\/71346","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9867\/71347","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/9867\/71346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:55:41Z","timestamp":1794045341000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/9867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":11,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,8,21]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2019.240762","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,5]]}}}